NxStage Medical Inc. (NSDQ:NXTM) beat its own guidance and analysts’ expectations during the first quarter, posting a 20 percent jump in sales and narrowing net losses by more than 26 percent.
The Lawrence, Mass.-based home hemodialysis products maker reported sales of $40.4 million for the three months ended March 31, up 19.8 percent compared with $33.7 million during the same period last year.